SEP 01, 2020 10:45 AM SGT

COVID-19 Vaccine Development

Speaker

Abstract

The ongoing COVID-19 pandemic has driven unprecedented efforts in vaccine research and development against the etiologic agent SARS-CoV-2. The usual timeframe for vaccine development, 5-10 years, has been reduced to 12-18 months, and in the past 8 months, roughly 200 vaccine development projects have been initiated. 24 vaccines are in human clinical trials, and Phase III activity has started for 2-3 candidate vaccines and will soon start for several more. While many are cautiously optimistic that we may prove that at least one vaccine is safe and effective, we cannot guarantee the timeframe, the durability of protection, or the long-term safety of these regimens. We will review the major published data from vaccine clinical trials and put them into the context of what is known or hypothesized about relevant immune responses and potential safety concerns. Finally we will address issues of manufacturing, access, and uptake that may profoundly affect the ability of COVID-19 vaccines to return us to the “old” normal.


Show Resources
You May Also Like
SEP 17, 2021 12:00 PM CST
C.E. CREDITS
SEP 17, 2021 12:00 PM CST
Date: September 16, 2021 Time: 9:00pm (PDT), 12:00am (EDT) 3D cellular models like organoids and spheroids offer an opportunity to better understand complex biology in a physiologically rele...
SEP 14, 2021 7:00 AM PDT
C.E. CREDITS
SEP 14, 2021 7:00 AM PDT
Date: September 14, 2021 Time: 7am PDT, 10am EDT, 4pm CEST A conventional thermal cycler has long been a commodity product in the lab and end-point PCR techniques can be completed almost wit...
DEC 01, 2021 7:00 AM PST
C.E. CREDITS
DEC 01, 2021 7:00 AM PST
Date: December 01, 2021 Time: 7:00am (PST), 10:00am (EST) In the era of immuno-oncology, there is a growing need for the identification of new biomarkers predictive for sensitivity to anti-P...
SEP 16, 2021 8:00 AM PDT
C.E. CREDITS
SEP 16, 2021 8:00 AM PDT
Date: September 16, 2021 Time: 8:00am (PDT), 11:00am (EDT) Rapid screening and speed of scale-up in protein therapeutics are critical factors in today’s biotech and pharma workflows. T...
DEC 07, 2021 10:00 AM PST
C.E. CREDITS
DEC 07, 2021 10:00 AM PST
Date: December 07, 2021 Time: 10:00am (PST) The RNAscope™ technology allows high sensitivity and spatial resolution providing pivotal single-cell information to gain better insights in...
JUN 24, 2021 8:00 AM PDT
C.E. CREDITS
JUN 24, 2021 8:00 AM PDT
Date: June 24, 2021 Time: 8:00am (PDT), 11:00am (EDT) Cardiovascular disease is a leading health problem, affecting almost 30% of individuals in the developed world, and comprises a wide ran...
Loading Comments...
Show Resources